Yifan Pharmaceutical Co., Ltd. (SHE: 002019)
China
· Delayed Price · Currency is CNY 10.69
-0.11 (-1.02%)
Feb 6, 2025, 10:30 AM CST
Yifan Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1,018 | 698.37 | 1,144 | 1,336 | 1,324 | 1,524 | Upgrade
|
| Trading Asset Securities | 65 | 75.01 | 95.5 | - | 46.73 | 39 | Upgrade
|
| Cash & Short-Term Investments | 1,083 | 773.38 | 1,239 | 1,336 | 1,371 | 1,563 | Upgrade
|
| Cash Growth | 32.15% | -37.59% | -7.25% | -2.51% | -12.30% | -11.36% | Upgrade
|
| Accounts Receivable | 1,457 | 1,209 | 1,258 | 1,145 | 1,102 | 1,000 | Upgrade
|
| Other Receivables | 101.65 | 80.69 | 112.08 | 120.16 | 130.17 | 120.5 | Upgrade
|
| Receivables | 1,559 | 1,290 | 1,370 | 1,265 | 1,232 | 1,121 | Upgrade
|
| Inventory | 1,065 | 928.61 | 830.97 | 663.87 | 583.85 | 598.19 | Upgrade
|
| Other Current Assets | 219.91 | 259.62 | 249.71 | 320.22 | 319.35 | 238.58 | Upgrade
|
| Total Current Assets | 3,926 | 3,251 | 3,690 | 3,585 | 3,506 | 3,520 | Upgrade
|
| Property, Plant & Equipment | 1,941 | 1,752 | 1,601 | 1,643 | 1,491 | 1,289 | Upgrade
|
| Long-Term Investments | 693.49 | 717.04 | 696.68 | 640.12 | 666.23 | 707.12 | Upgrade
|
| Goodwill | 2,737 | 2,737 | 2,738 | 2,738 | 2,750 | 2,728 | Upgrade
|
| Other Intangible Assets | 1,795 | 1,683 | 751.37 | 658.21 | 715.63 | 719.12 | Upgrade
|
| Long-Term Accounts Receivable | 23.42 | 1.43 | 2.16 | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 244.45 | 257.81 | 291.47 | 244.38 | 226.34 | 163.62 | Upgrade
|
| Long-Term Deferred Charges | 846.24 | 964.14 | 2,592 | 2,474 | 2,187 | 1,901 | Upgrade
|
| Other Long-Term Assets | 162.81 | 136.08 | 181.38 | 182.71 | 95.33 | 38.32 | Upgrade
|
| Total Assets | 12,370 | 11,500 | 12,544 | 12,165 | 11,637 | 11,066 | Upgrade
|
| Accounts Payable | 471.13 | 431.36 | 288.4 | 350.86 | 381.19 | 418.99 | Upgrade
|
| Accrued Expenses | 123.97 | 387.69 | 360.56 | 219.84 | 180.43 | 182.17 | Upgrade
|
| Short-Term Debt | 1,012 | 609.05 | 673.96 | 1,020 | 1,193 | 1,784 | Upgrade
|
| Current Portion of Long-Term Debt | 739.88 | 489.77 | 554.03 | 419.27 | 17.67 | 41.93 | Upgrade
|
| Current Portion of Leases | - | 17.6 | 17.95 | 14.54 | 0.49 | 0.41 | Upgrade
|
| Current Income Taxes Payable | 88.99 | 19.14 | 29.54 | 24.19 | 33.8 | 85.27 | Upgrade
|
| Current Unearned Revenue | 110.7 | 133.23 | 203.26 | 94.82 | 62.68 | 69.13 | Upgrade
|
| Other Current Liabilities | 437.21 | 99.53 | 71.69 | 158.53 | 259.6 | 300.99 | Upgrade
|
| Total Current Liabilities | 2,984 | 2,187 | 2,199 | 2,302 | 2,129 | 2,883 | Upgrade
|
| Long-Term Debt | 703.85 | 812.04 | 850.17 | 730.51 | 447.63 | 83.97 | Upgrade
|
| Long-Term Leases | 52.35 | 66.73 | 80.69 | 89.8 | 0.95 | 1.21 | Upgrade
|
| Long-Term Unearned Revenue | 130.79 | 102.16 | 107.29 | 104.12 | 88.36 | 49.62 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 56.83 | 54.52 | 140.9 | 148.28 | 225.13 | 211.98 | Upgrade
|
| Other Long-Term Liabilities | 22.83 | 21.86 | 18.94 | 16.02 | - | - | Upgrade
|
| Total Liabilities | 3,950 | 3,245 | 3,397 | 3,391 | 2,907 | 3,244 | Upgrade
|
| Common Stock | 1,037 | 1,046 | 1,046 | 1,054 | 1,055 | 1,057 | Upgrade
|
| Additional Paid-In Capital | 2,844 | 2,993 | 2,993 | 3,048 | 3,041 | 2,953 | Upgrade
|
| Retained Earnings | 4,599 | 4,354 | 4,905 | 4,712 | 4,505 | 3,660 | Upgrade
|
| Treasury Stock | - | -159 | -121.01 | -186.72 | -127.02 | -199.33 | Upgrade
|
| Comprehensive Income & Other | 33.66 | 41.31 | -11.36 | -92.36 | -34.22 | 28.84 | Upgrade
|
| Total Common Equity | 8,513 | 8,276 | 8,812 | 8,535 | 8,440 | 7,500 | Upgrade
|
| Minority Interest | -93.64 | -20.73 | 334.75 | 239.38 | 290.36 | 322.14 | Upgrade
|
| Shareholders' Equity | 8,419 | 8,255 | 9,147 | 8,775 | 8,730 | 7,822 | Upgrade
|
| Total Liabilities & Equity | 12,370 | 11,500 | 12,544 | 12,165 | 11,637 | 11,066 | Upgrade
|
| Total Debt | 2,508 | 1,995 | 2,177 | 2,274 | 1,660 | 1,912 | Upgrade
|
| Net Cash (Debt) | -1,425 | -1,222 | -937.51 | -937.76 | -289.32 | -349.27 | Upgrade
|
| Net Cash Per Share | -1.17 | -1.00 | -0.74 | -0.77 | -0.24 | -0.29 | Upgrade
|
| Filing Date Shares Outstanding | 1,216 | 1,216 | 1,219 | 1,207 | 1,148 | 1,235 | Upgrade
|
| Total Common Shares Outstanding | 1,216 | 1,216 | 1,219 | 1,207 | 1,148 | 1,235 | Upgrade
|
| Working Capital | 942.35 | 1,064 | 1,491 | 1,284 | 1,377 | 637 | Upgrade
|
| Book Value Per Share | 7.00 | 6.80 | 7.23 | 7.07 | 7.35 | 6.07 | Upgrade
|
| Tangible Book Value | 3,980 | 3,855 | 5,323 | 5,139 | 4,975 | 4,053 | Upgrade
|
| Tangible Book Value Per Share | 3.27 | 3.17 | 4.37 | 4.26 | 4.33 | 3.28 | Upgrade
|
| Buildings | - | 973.8 | 914.2 | 931.78 | 841.79 | 686.3 | Upgrade
|
| Machinery | - | 1,443 | 1,357 | 1,232 | 1,071 | 1,020 | Upgrade
|
| Construction In Progress | - | 313.31 | 175.8 | 257.46 | 415.22 | 342.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.